These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 26067887)

  • 1. Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay.
    Naik RD; Vaezi MF
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):969-82. PubMed ID: 26067887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-esophageal manifestations of gastroesophageal reflux.
    Farrokhi F; Vaezi MF
    Oral Dis; 2007 Jul; 13(4):349-59. PubMed ID: 17577320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra-esophageal manifestations of GERD: who responds to GERD therapy?
    Naik RD; Vaezi MF
    Curr Gastroenterol Rep; 2013 Apr; 15(4):318. PubMed ID: 23435747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment.
    Hom C; Vaezi MF
    Drugs; 2013 Aug; 73(12):1281-95. PubMed ID: 23881666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraesophageal manifestations of gastroesophageal reflux disease: real or imagined?
    Moore JM; Vaezi MF
    Curr Opin Gastroenterol; 2010 Jul; 26(4):389-94. PubMed ID: 20473157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraesophageal presentations of GERD: where is the science?
    Madanick RD
    Gastroenterol Clin North Am; 2014 Mar; 43(1):105-20. PubMed ID: 24503362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.
    Patel DA; Sharda R; Choksi YA; Slaughter JC; Higginbotham T; Garrett CG; Francis DO; Ravi K; Hasak S; Katzka D; Gyawali CP; Vaezi MF
    Gastroenterology; 2018 Dec; 155(6):1729-1740.e1. PubMed ID: 30170117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical presentations of gastroesophageal reflux disease.
    Heidelbaugh JJ; Gill AS; Van Harrison R; Nostrant TT
    Am Fam Physician; 2008 Aug; 78(4):483-8. PubMed ID: 18756656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and initial management of gastroesophageal complications.
    Kamal A; Vaezi MF
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):799-820. PubMed ID: 21126695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra-esophageal presentation of gastroesophageal reflux disease: new understanding in a new era.
    Martinucci I; Albano E; Marchi S; Blandizzi C
    Minerva Gastroenterol Dietol; 2017 Sep; 63(3):221-234. PubMed ID: 28260352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflux monitoring: on or off therapy?
    Vaezi MF
    Am J Gastroenterol; 2011 Feb; 106(2):183-5. PubMed ID: 21301447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
    Yadlapati R; Gyawali CP; Pandolfino JE;
    Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Noncardiac chest pain and gastroesophageal reflux disease].
    Dimache M; Turcan E; Nătase M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):342-8. PubMed ID: 20700964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antireflux surgery in the proton pump inhibitor era.
    Bulsiewicz WJ; Madanick RD
    Cleve Clin J Med; 2012 Apr; 79(4):273-81. PubMed ID: 22473727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraesophageal GERD.
    Frye JW; Vaezi MF
    Gastroenterol Clin North Am; 2008 Dec; 37(4):845-58, ix. PubMed ID: 19028321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.